DEA registers 900 medical marijuana shops, unlocking federal tax deductions

The Drug Enforcement Administration issued its first set of registrations to medical marijuana dispensaries on Friday. The agency granted approval to more than 900 state-licensed locations in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia. This action follows a bureaucratic shift that aims to integrate these businesses into the federal regulatory framework.

Attorney General Todd Blanche signed an order in April to reclassify state-licensed medical marijuana from Schedule I to Schedule III. Schedule I is reserved for drugs with no accepted medical use and a high potential for abuse. The move to Schedule III subjects the substance to less strict federal oversight while establishing a pathway for producers and distributors to register with the DEA.

In a news release, the Justice Department stated that Blanche believes the regulated distribution of medical cannabis will improve access to chronic pain treatment. He also cited the safety of the American people as a primary benefit of the new registration process. The department did not immediately identify the specific businesses that received the initial approvals.

The immediate financial impact for industry operators is expected to be substantial. Under previous rules, state-licensed cannabis companies were treated as dealing with a federally illegal Schedule I substance. This classification prevented them from deducting standard business expenses such as rent, labor, and advertising on federal tax returns. Industry leaders have described this tax burden as financially crippling for many operators.

DEA officials published a list on Friday showing that nearly 7,000 other cannabis dispensaries, manufacturers, and distributors have applied for registration. To obtain approval, businesses must undergo a pre-registration investigation. They must also demonstrate adequate security, recordkeeping, and inventory controls consistent with the handling of controlled substances.

Steph Sherer, founder of Americans for Safe Access, noted that the approvals arrived just days before the 30th anniversary of California becoming the first state to legalize medical marijuana. She stated in a written release that the federal government is finally recognizing the dispensaries that patients fought to establish. Sherer called the move a tremendous victory for patient access.

Uncertainty remains regarding how the DEA will enforce regulations for these new registrants. State laws often allow individuals with certain criminal histories to operate licensed marijuana businesses, a practice that may conflict with federal oversight. Additionally, it is unclear how the agency will handle companies that operate both recreational and medical marijuana programs, as many states have merged these sectors.

Twenty-four states and Washington, D.C., have authorized adult recreational use of marijuana. Forty states have medical marijuana systems, and eight others permit low-THC cannabis or CBD oil for medical use. Only Idaho and Kansas currently ban marijuana entirely. Chris Lindsey, vice president of policy at the American Trade Association for Cannabis and Hemp, said the industry is watching to see what specific operational requirements the DEA imposes now that companies are entering this regulatory class.